Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

TCR2 Therapeutics Inc. (TCRR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.2900+0.0200 (+1.57%)
At close: 01:00PM EST
1.2900 -0.01 (-0.45%)
After hours: 01:01PM EST
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
0
Operating Expense
119,694
99,742
68,700
51,382
26,453
Operating Income
-119,694
-99,742
-68,700
-51,382
-26,453
Net Non Operating Interest Income Expense
963
224
1,737
3,885
-
Other Income Expense
-
-
-
-
2,202
Pretax Income
-118,731
-99,518
-66,963
-47,497
-24,251
Tax Provision
325
289
161
102
-
Net Income Common Stockholders
-119,056
-99,807
-67,124
-97,499
-61,549
Diluted NI Available to Com Stockholders
-119,056
-99,807
-67,124
-97,499
-61,549
Basic EPS
-
-2.63
-2.40
-4.62
-2.65
Diluted EPS
-
-2.63
-2.40
-4.62
-2.65
Basic Average Shares
-
37,936
27,991
21,104
23,190
Diluted Average Shares
-
37,936
27,991
21,104
23,190
Total Operating Income as Reported
-119,694
-99,742
-68,700
-51,382
-26,453
Total Expenses
119,694
99,742
68,700
51,382
26,453
Net Income from Continuing & Discontinued Operation
-119,056
-99,807
-67,124
-47,599
-24,251
Normalized Income
-119,056
-99,807
-67,124
-47,599
-24,251
Interest Income
963
224
1,737
-
-
Net Interest Income
963
224
1,737
3,885
-
EBIT
-119,694
-99,742
-68,700
-51,382
-26,453
EBITDA
-116,543
-
-
-
-
Reconciled Depreciation
3,151
2,827
1,592
862
419
Net Income from Continuing Operation Net Minority Interest
-119,056
-99,807
-67,124
-47,599
-24,251
Normalized EBITDA
-116,543
-96,915
-67,108
-50,520
-26,034
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement